As more exercise guidelines for using a GLP-1 are updated from the research, fitness professionals should treat GLP-1 users similarly to weight loss clients
Tambin existe una versin oral de semaglutida (Rybelsus) aprobada solo para diabetes, no para control de peso
CKD is a principal microvascular complication of diabetes and increases the risk of CVD and death [3]
The competitive landscape has seen significant activity and controversy
The Circana study found that households with members taking the weight loss drugs typically spend more on CPG [consumer packaged goods] food, beverages, and foodservice before they initiate use of a GLP-1 than non-user households, a trend that continues even in the first year of drug use. It also found that GLP-1 weight loss users: Reduced relative household spending on spicy foods, fatty proteins, and beverages with added sugar, and increased spending on vegetables, eggs, and nuts Spent more on gum, mints, and non-chocolate candy to provide relief from the drugs side effects including bad breath and dry mouth Increased spending on drinkware and water filtration versus non-users, which could be driven by hydration recommendations Spent more on gastrointestinal products for relief from side effects of the medication Spent less on sleep remedies, analgesics, home health care, and foot care products Spent less on frozen foods and more in the produce and deli departments Spent more on foods & beverages at drug stores, perhaps because they are going there regularly to pick up meds Further reading: How are GLP-1 drugs impacting spending on food and dietary supplements
